Login / Signup

Reopening schools safely in the face of COVID-19: Can cluster randomized trials help?

Charles WeijerKarla HemmingSpencer Phillips HeyHolly Fernandez Lynch
Published in: Clinical trials (London, England) (2021)
The COVID-19 pandemic has highlighted the challenges of evidence-based health policymaking, as critical precautionary decisions, such as school closures, had to be made urgently on the basis of little evidence. As primary and secondary schools once again close in the face of surging infections, there is an opportunity to rigorously study their reopening. School-aged children appear to be less affected by COVID-19 than adults, yet schools may drive community transmission of the virus. Given the impact of school closures on both education and the economy, schools cannot remain closed indefinitely. But when and how can they be reopened safely? We argue that a cluster randomized trial is a rigorous and ethical way to resolve these uncertainties. We discuss key scientific, ethical, and resource considerations both to inform trial design of school reopenings and to prompt discussion of the merits and feasibility of conducting such a trial.
Keyphrases
  • mental health
  • physical activity
  • coronavirus disease
  • healthcare
  • sars cov
  • study protocol
  • phase iii
  • clinical trial
  • public health
  • young adults
  • phase ii
  • quality improvement
  • open label
  • social media